In Brief This Week: CBLPath, Roche; Complete Genomics; Gen-Probe; Sigma-Aldrich; Warnex; BD | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CBLPath has received approval in New York to offer in-house Roche's cobas 4800 BRAF V600 Mutation Test for metastatic melanoma. The approval from the New York State Department of Health makes CBLPath one of a few laboratories in the US to offer the test, the Rye Brook, NY-based lab said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.